Balyasny Asset Management L.P.

13D and 13G Filings

Issuer % of Class Filed
Schedule 13G · 46 securities · passive
Beyond Air, Inc. 13G/A
XAIR · 08862L301
10.0% 11/16/2026
Event 9/30/2026
TXNM Energy, Inc. 13G/A
TXNM · 69349H107
6.6% 11/16/2026
Event 9/30/2026
Tandem Diabetes Care, Inc. 13G
TNDM · 875372203
5.2% 11/16/2026
Event 9/30/2026
Surrozen, Inc. 13G
SRZN · 86889P208
5.6% 11/16/2026
Event 9/30/2026
Sagimet Biosciences Inc. 13G/A
SGMT · 786700104
9.0% 11/16/2026
Event 9/30/2026
SAB Biotherapeutics, Inc. 13G/A
SABS · 78397T202
7.9% 11/16/2026
Event 9/30/2026
Research Alliance Corporation IV 13G
RACD · G75228109
5.1% 11/16/2026
Event 9/30/2026
Research Alliance Corporation III 13G/A
RACC · G75226103
6.1% 11/16/2026
Event 9/30/2026
Nasus Pharma Ltd. 13G/A
NSRX · M7071P109
10.0% 11/16/2026
Event 9/30/2026
Neurogene Inc. 13G/A
NGNE · 64135M105
1.5% 11/16/2026
Event 9/30/2026
Minerva Neurosciences, Inc. 13G/A
NERV · 603380205
10.0% 11/16/2026
Event 9/30/2026
Lexeo Therapeutics, Inc. 13G/A
LXEO · 52886X107
10.0% 11/16/2026
Event 9/30/2026
Korsana Biosciences, Inc. 13G/A
KRSA · 23255M303
1.3% 11/16/2026
Event 9/30/2026
Korro Bio, Inc. 13G/A
KRRO · 500946108
5.9% 11/16/2026
Event 9/30/2026
Jatt II Acquisition Corp 13G/A
JATT · G50765109
6.4% 11/16/2026
Event 9/30/2026
Irulya Therapeutics Inc. 13G/A
IRLA · 22053A305
10.0% 11/16/2026
Event 9/30/2026
Opus Genetics Inc. 13G/A
IRD · 67577R102
7.4% 11/16/2026
Event 9/30/2026
Werewolf Therapeutics, Inc. 13G
HOWL · 95075A107
6.3% 11/16/2026
Event 9/30/2026
Helix Acquisition Corp. III 13G/A
HLXC · G4444S107
5.6% 11/16/2026
Event 9/30/2026
Cue Biopharma, Inc. 13G
CUE · 22978P205
5.9% 11/16/2026
Event 9/30/2026
Contineum Therapeutics, Inc. 13G/A
CTNM · 21217B100
7.4% 11/16/2026
Event 9/30/2026
Cellectar Biosciences, Inc. 13G/A
CLRB · 15117F880
10.0% 11/16/2026
Event 9/30/2026
Crescent Biopharma, Inc. 13G/A
CBIO · 38000Q201
4.3% 11/16/2026
Event 9/30/2026
Beyond Air, Inc. 13G/A
XAIR · 08862L202
Amended under CUSIP 08862L301 on 11/16/2026
5.3% 8/14/2026
Event 6/30/2026
Talkspace, Inc 13G/A
TALK · 87427V103
4.1% 8/14/2026
Event 6/30/2026
SkyWater Technology, Inc. 13G
SKYT · 83089J108
6.4% 8/14/2026
Event 6/30/2026
Rezolute, Inc. 13G/A
RZLT · 76200L309
4.8% 8/14/2026
Event 6/30/2026
Rallybio Corp 13G/A
RLYB · 75120L209
0% 8/14/2026
Event 6/30/2026
Ovid Therapeutics Inc. 13G/A
OVID · 690469101
4.99% 8/14/2026
Event 6/30/2026
Helix Acquisition Corp. III 13G/A
TXNM · 69349H107
Amended under CUSIP G4444S107 on 11/16/2026
7.0% 8/14/2026
Event 6/30/2026
Cyclerion Therapeutics, Inc. 13G
CYCN · 23255M204
Amended under CUSIP 23255M303 on 11/16/2026
7.3% 8/14/2026
Event 6/30/2026
Camp4 Therapeutics Corp. 13G/A
CAMP · 13463J101
4.99% 8/14/2026
Event 6/30/2026
Enhabit, Inc. 13G/A
EHAB · 29332G102
5.2% 5/15/2026
Event 3/31/2026
Verastem Inc. 13G/A
VSTM · 92337C203
1.6% 5/15/2026
Event 3/31/2026
Nasus Pharma Ltd 13G
IL001218553
Amended under CUSIP M7071P109 on 8/14/2026
10.0% 5/15/2026
Event 3/31/2026
Korro Bio, Inc. 13G
KRRO · 500946108
7.2%
Checked 5% or less
5/15/2026
Event 3/31/2026
Avalo Therapeutics Inc. 13G/A
AVTX · 05338F306
2.4% 2/17/2026
Event 12/31/2025
Arcturus Therapeutics Holdings Inc. 13G/A
ARCT · 03969T109
0% 2/17/2026
Event 12/31/2025
Spirit AeroSystems Holdings, Inc. 13G/A
SPR · 848574109
5.5% 11/14/2025
Event 9/30/2025
Lottery.com Inc 13G/A
LTRYW · 54570M116
4.0% 11/14/2025
Event 10/3/2025
Camping World Holdings, Inc 13G/A
CWH · 13462K109
4.0% 11/14/2025
Event 9/30/2025
Shapeways Holdings, Inc 13G/A
SHPSQ · 81947T110
0.9% 8/14/2025
Event 6/30/2025
Beyond Air, Inc. 13G/A
XAIR · 08862L103
10.0% 5/15/2025
Event 3/31/2025
Hudson Pacific Properties, Inc 13G/A
HPP · 444097109
4.99% 5/15/2025
Event 3/31/2025
Leap Therapeutics, Inc. 13G/A
CYPH · 52187K200
0% 2/14/2025
Event 12/31/2024
Shapeways Holdings Inc 13G/A
81947T100
Amended under CUSIP 81947T110 on 5/15/2025
7.0% 2/14/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.